Dette randomiserede forsøg med patienter med metastatisk colorectal- cancer, som ikke tidligere havde fået behandling for metastatisk sygdom, sammenlignede kombinationen af cetuximab og irinotecan plus 5- fluorouracil/ folinsyre- infusion (5- FU/ FA) (599 patienter) med den samme kemoterapibehandling uden cetuximab (599 patienter).
This randomised study in patients with metastatic colorectal cancer who had not received prior treatment for metastatic disease compared the combination of cetuximab and irinotecan plus infusional 5-fluorouracil/ folinic acid (5-FU/ FA) (599 patients) to the same chemotherapy alone (599 patients).